Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

MX Mexiko City Moreno-Sanchez R

From Bioblast

                



MX Mexiko City Moreno-Sanchez R

Oroboros O2k-Network

O2k-Network
O2k-Network Lab Departamento de BioquĂ­mica

Instituto Nacional de CardiologĂ­a

Address ,
City Mexico City
State/Prov
Country Mexico
Weblink
Contact Moreno-Sanchez Rafael
Team Rodriguez-Enriquez S
Team previous
Status O2k 2015-
Oroboros Events
Topics


O2k-Publications

 PublishedReference
Robledo-Cadena 2020 Pharmaceuticals (Basel)2020Robledo-Cadena DX, Gallardo-PĂ©rez JC, DĂĄvila-Borja V, Pacheco-VelĂĄzquez SC, Belmont-DĂ­az JA, Ralph SJ, Blanco-Carpintero BA, Moreno-SĂĄnchez R, RodrĂ­guez-EnrĂ­quez S (2020) Non-steroidal anti-inflammatory drugs increase cisplatin, paclitaxel, and doxorubicin efficacy against human cervix cancer cells. Pharmaceuticals (Basel) 13:463.
Rodriguez-Enriquez 2019 Toxicol Appl Pharmacol2019Rodríguez-Enríquez S, Pacheco-Velåzquez SC, Marín-Hernåndez Á, Gallardo-Pérez JC, Robledo-Cadena DX, Hernåndez-Reséndiz I, García-García JD, Belmont-Díaz J, López-Marure R, Hernåndez-Esquivel L, Sånchez-Thomas R, Moreno-Sånchez R (2019) Resveratrol inhibits cancer cell proliferation by impairing oxidative phosphorylation and inducing oxidative stress. Toxicol Appl Pharmacol 370:65-77.
Pacheco-Velazquez 2018 Mol Pharm2018Pacheco-Velåzquez SC, Robledo-Cadena DX, Hernåndez-Reséndiz I, Gallardo-Pérez JC, Moreno-Sånchez R, Rodríguez-Enríquez S (2018) Energy metabolism drugs block triple negative breast metastatic cancer cell phenotype. Mol Pharm 15:2151-64.
Hernandez-Resendiz 2018 J Cell Physiol2018Hernåndez-Reséndiz I, Gallardo-Pérez JC, López-Macay A, Robledo-Cadena DX, García-Villa E, Gariglio P, Saavedra E, Moreno-Sånchez R, Rodríguez-Enríquez S (2018) Mutant p53R248Q downregulates oxidative phosphorylation and upregulates glycolysis under normoxia and hypoxia in human cervix cancer cells. J Cell Physiol 234:5524-36.

O2k-Abstracts

update please